A 32-year-old with severe atopic dermatitis refractory to optimized topical therapy asks about systemic options. Which is supported by guidelines?...

Question

A 32-year-old with severe atopic dermatitis refractory to optimized topical therapy asks about systemic options. Which is supported by guidelines?

Accepted Answer

Dupilumab or JAK inhibitors in selected patients

Answer

Long-term systemic corticosteroids as maintenance

Answer

Chronic broad-spectrum antibiotics

Answer

No phototherapy use

Answer

Topical therapy only

us-abfm MCQ (SBA): Atopic Dermatitis-Systemic Therapy